Baxter International Inc. (BAX)

82.97
NYSE
Prev Close 82.32
Day Low/High 82.16 / 83.79
52 Wk Low/High 69.10 / 95.19
Exchange NYSE
Shares Outstanding 506.23B
Market Cap 41.67B
P/E Ratio 45.99
Div & Yield N.A. (N.A)

Latest News

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.

I'm Dusting Off My Old Playbook for Bonds Right Now

I'm Dusting Off My Old Playbook for Bonds Right Now

After a strong day for fixed-income markets, let's learn from 2008 how to play this volatility.

Jim Cramer: More News Will Move More Stocks

Jim Cramer: More News Will Move More Stocks

What if a stock is being propelled by actual events or changes?

Baxter International's Prognosis Looks Poor, Consider Selling

Baxter International's Prognosis Looks Poor, Consider Selling

BAX saw shares plunge 10% last week on news of accounting irregularities and the charts appear bearish.

Baxter International Breaks Its February/April Lows: Now What?

Baxter International Breaks Its February/April Lows: Now What?

BAX is now in a weak technical position.

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Here's Why the Market Rally Has Staying Power

Jim Cramer: Here's Why the Market Rally Has Staying Power

For most of this year the market has been led by growth stocks.

The Dip in Baxter International Should Soon Be a Buying Opportunity

The Dip in Baxter International Should Soon Be a Buying Opportunity

BAX declined recently to break the rising 50-day moving average line.

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits

Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits

When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Why Value Investor Benjamin Graham Remains Relevant Today

Why Value Investor Benjamin Graham Remains Relevant Today

I still also use Graham-inspired stock screens, including one based on his 'stocks for the defensive investor' methodology.

Cramer: The 12 Strongest Sectors Going Into Earnings

Cramer: The 12 Strongest Sectors Going Into Earnings

It is incredibly healthy to see so many stocks so strong, from so many sectors.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

This week's bullish and bearish reversal patterns.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

These 'Rocket Stocks' Look Ready for Blastoff

These 'Rocket Stocks' Look Ready for Blastoff

These four stocks are showing short-term gain catalysts and longer-term growth potential.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Baxter's Chart Is Still Bullish

Baxter's Chart Is Still Bullish

Our price objective is $68.

Retail Stocks Don't Make Good Value Plays

Retail Stocks Don't Make Good Value Plays

Five names to consider from my 'stocks for the defensive investor' screen.

Baxter International Maintains Its Long-Running Uptrend

Baxter International Maintains Its Long-Running Uptrend

Recent upside breakout refreshes bull trend.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Baxter Buys Claris Injectables for $625 Million

Baxter Buys Claris Injectables for $625 Million

Baxter buys generic drug maker Claris Injectables in a deal that will be accretive to earnings.

Finding the Bullish and Bearish Reversals

Finding the Bullish and Bearish Reversals

Companies that marked turnarounds -- for better or worse -- last week.

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Check out the names that are showing technical characteristics of bullish or bearish reversal patterns over the last week.

Cramer: The Answer to This Market: Part 1

Cramer: The Answer to This Market: Part 1

The leadership is quite stark.